Joshua Reed - Chief Financial Officer, Aldeyra Therapeutics, Inc

As of April 14, 2021


Joshua Reed Net Worth

  • Net worth is estimated to be at least $1.07M
  • Owns at least 35,774 units of Aldeyra Therapeutics, Inc stock

Joshua Reed Trading

  • Largest purchase of shares was 3,200 units , worth over $15.07K on September 9, 2019
  • In total has made about 5 transactions over 3 years
  • Usually trades in March, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Joshua Reed Mailing Address

  • Mailing address is C/o Aldeyra Therapeutics, Inc. 131 Hartwell Avenue, Suite 320 Lexington MA 02421 MA

Aldeyra Therapeutics, Inc Insider Trading

  • The most recent transaction was 1,200,000 units bought on May 4, 2021 by Perceptive Advisors Llc, Perceptive Life Sciences Master Fund Ltd and Joseph Edelman worth over $15M
  • In the last 7 years, insiders at Aldeyra Therapeutics, Inc sold an estimated value of $1.97M and bought an estimated value of $64.92M
  • The most active traders are Todd C Brady, President and CEO,  Joseph Edelman,  and Perceptive Advisors Llc
  • Insider trading is most common in June, with the busiest year in 2019

Aldeyra Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1